KRAS and neoplasm: Interestingly, a slightly reduced Tm was detected in the group of patients having a nonmutated KRAS at the tumor level compared to their corresponding healthy tissues, suggesting that other CG → AT mutations located at different nucleotide positions of Gly12 and Gly13 could be present.